Rhagolwg
My research focuses on the design, synthesis and biological evaluation of novel therapeutic and diagnostic agents across infectious diseases, oncology and neurodegeneration. I have extensive expertise in synthetic organic chemistry, medicinal chemistry, natural product鈥搃nspired drug discovery, and structure鈥揳ctivity relationship (SAR) development. My work spans the synthesis of new antibiotics, antituberculosis agents, kinase inhibitors for triple鈥憂egative breast cancer, antitrypanosomal compounds for Chagas disease, and antiviral candidates targeting CHIKV. I also develop next鈥慻eneration diagnostic tools for neurodegenerative diseases through chemical antibody technologies in collaboration with leading UK and international partners.
Cymwysterau
- BSc: Pharmaceutical Sciences
Aleppo University, - Profesiynol: Fellowship in teaching, Advance HE
Higher Education Academy, - MSc: Medicinal Chemistry
University of Paris-Sud, - PhD in Medicinal Chemistry
University of Paris-Sud, - Profesiynol: The Postgraduate Certificate in Higher Education Teaching (PGCHET)
University of Sussex,
Addysgu ac Arolygiaeth
She is proud to hold a Fellowship with the UK Higher Education Academy (FHEA), a recognition of her dedication to high-quality teaching and learning. This accreditation has shaped her approach to curriculum design, assessment strategies, small-group teaching, and undergraduate research supervision. She has extensive experience in developing and delivering innovative MPharm and MSc programs, with a strong emphasis on inclusive education, study skills enhancement, and career development support for both domestic and international students. At Bangor, she teaches chemistry in the Mpharm program (MSE-0012, MSE-1033-MSE-1034, MSE-1036 and MSE-0013), leads module MSE-0013, and serves as the Foundation Year Lead.
Hadia is currently supervising undergraduate research projects and welcomes undergraduate students to apply.
Diddordebau Ymchwil
Hadia's research focuses on the design, synthesis and biological evaluation of novel therapeutic and diagnostic agents across infectious diseases, oncology and neurodegeneration. She has extensive expertise in synthetic organic chemistry, medicinal chemistry, natural product鈥搃nspired drug discovery, and structure鈥揳ctivity relationship (SAR) development. My work spans the synthesis of new antibiotics, antituberculosis agents, kinase inhibitors for triple鈥憂egative breast cancer, antitrypanosomal compounds for Chagas disease, and antiviral candidates targeting CHIKV. She also develop next鈥慻eneration diagnostic tools for neurodegenerative diseases through chemical antibody technologies in collaboration with leading UK and international partners.
Cyfleoedd Project 脭l-radd
1- Development of new anticancer drugs
2- Development of neurodegenerative diseases treatment
3- Development of new antivirals
Blaenorol
To share her research and engage with the global scientific community, she has participated in over 45 international conferences and symposiums across Europe, Japan, the UK, the UAE, Egypt, and Syria.聽 She actively contributes to scholarly publishing as a regular reviewer for leading Q1 journals such as Frontiers in Chemistry, Journal of Drug Delivery Science and Technology, International Journal of Biological Macromolecules, and various MDPI journals. She has been recognized as a trusted reviewer and currently serve on the editorial board of the Archive of Advanced Chemistry Journal, as well as a guest editor for MDPI journals.
Beyond academia, she鈥檚 passionate about making science accessible to younger generations. As a STEM ambassador, she actively supports school outreach initiatives, inspiring future scientists and promoting engagement with the pharmaceutical sciences